Sequential gene expression profiling in lung transplant recipients with chronic rejection

Chest

Volumn 130, Issue 3, 2006, Pages 847-854

  Lu, Brandon S ^a,e   Yu, Andrew D ^b   Zhu, Xiaofeng ^c   Garrity Jr , Edward R ^d   Vigneswaran, Wickii T ^d   Bhorade, Sangeeta M ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DuPage Medical Group   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

BAL; Graft rejection; Lung transplantation; Microarray analysis

Indexed keywords

AZATHIOPRINE; PREDNISONE; RAPAMYCIN; RNA; TACROLIMUS;

ADULT; APOPTOSIS; ARTICLE; BRONCHOSCOPY; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ISOLATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; MORBIDITY; MORTALITY; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA HYBRIDIZATION; SURVIVAL TIME;

EID: 33748857907     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.3.847     Document Type: Article

References (34)

1. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999; 340:1081-1091
2. Trulock EP, Edwards LB, Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report; 2003. J Heart Lung Transplant 2003; 22:625-635
3. Boehler A, Kesten S, Weder W, et al. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998; 114:1411-1426
4. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15:1-15
5. Bowdish ME, Arcasoy SM, Wilt JS, et al. Surrogate markers and risk factors for chronic lung allograft dysfunction. Am J Transplant 2004; 4:1171-1178
6. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166:440-444
7. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21:297-310
8. Tusher VG, Tibshirani R, Chu G. Significance of analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98:5116-5121
9. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95:14863-14868
10. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001; 344:539-548
11. Bullinger L, Döhner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350:1605-1616
12. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349:125-138
13. Scherer A, Krause A, Walker JR, et al. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 2003; 75:1323-1330
14. Puskas LG, Nagy ZB, Giricz Z, et al. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Letters 2004; 562:99-104
15. Gimino VJ, Lande JD, Berryman TR, et al. Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection. Am J Respir Crit Care Med 2003; 168:1237-1242
16. Aris RM, Walsh S, Chalermskulrat W, et al. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med 2002; 166:417-422
17. Hansen PR, Holm AM, Svendsen UG, et al. Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis. J Heart Lung Transplant 2000; 19:160-166
18. Hertz MI, Henke CA, Nakhleh RE, et al. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci U S A 1992; 89:10385-10389
19. Kallio EA, Koskinen PK, Aavik E, et al. Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat. Am J Respir Crit Care Med 1999; 160:1324-1332
20. Koskinen P, Kallio E, Tikkanen J, et al. Cytomegalovirus infection accelerates experimental obliterative bronchiolitis via platelet-derived growth factor upregulation. Transplant Proc 1997; 29:798
21. Kuwano K, Hagimoto N, Kawasaki M, et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999; 104:13-19
22. Maeyama T, Kuwano K, Kawasaki M, et al. Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J 2001; 17:180-189
23. Selman M, King TE Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136-151
24. Zheng L, Ward C, Snell GI, et al. Scar collagen deposition in the airways of allografts of lung transplant recipients. Am J Respir Crit Care Med 1997; 155:2072-2077
25. Charpin J, Valcke J, Kettaneh L, et al. Peaks of transforming growth factor-β mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation 1998; 65:752-755
26. Charpin JM, Stern M, Grenet D, et al. Insulin-like growth factor-1 in lung transplants with obliterative bronchiolitis. Am J Respir Crit Care Med 2000; 161:1991-1998
27. DiGiovine B, Lynch JP III, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation. J Immunol 1996; 157:4194-4202
28. Elssner A, Jaumann F, Dobmann S, et al. Elevated levels of interleukin-8 and transforming growth factor-β in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Transplantation 2000; 70:362-367
29. Magnan A, Mege JL, Escallier JC, et al. Balance between alveolar macrophage IL-6 and TGF-β in lung-transplant recipients. Am J Respir Crit Care Med 1996; 153:1431-1436
30. Riise GC, Andersson BA, Kjellström C, et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 1999; 14:1123-1130
31. Scholma J, Slebos DJ, Boezen HM, et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000; 162:2221-2225
32. Boehler A, Bai XH, Liu M, et al. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med 1999; 159:1910-1917
33. Murakawa T, Kerklo MM, Zamora MR, et al. Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis. J Immunol 2005; 174:3869-3879
34. Smith CR, Jaramillo A, Lu KC, et al. Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor. Transplantation 2001; 72:1512-1518